Frank David 12/10/16 Frank David 12/10/16

Why Pharma Undervalues Novel R&D

New data on drug ramp rates could increase the financial attractiveness of “pioneer” projects.

Frank David 1/1/15 Frank David 1/1/15

Drug pricing is the new Big Pharma giant-killer

Is the new contracting deal in hepatitis C a meaningless blip, or the “end of days” for biopharma? (Spoiler alert: "no” and “no”.)

Frank David 8/12/14 Frank David 8/12/14

Pharma commercial teams are doing business like it's 2004 ... or maybe even 1994. It's time for a reboot.

Frank David 12/17/13 Frank David 12/17/13

Can you think of a good reason to have a Pharma sales force? Neither can I.